about
Prolonged activation of virus-specific CD8+T cells after acute B19 infection.Chlamydia-Like Organisms (CLOs) in Finnish Ixodes ricinus Ticks and Human SkinReal-time PCR in clinical microbiology: applications for routine laboratory testing.Parvovirus transmission by blood products - a cause for concern?Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia.Genetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1Discovery and genomic characterization of a novel ovine partetravirus and a new genotype of bovine partetravirus.Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.Advances in human B19 erythrovirus biologyCharacterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptomsReactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemicBioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissueParvovirus B19 - Revised.Human erythrovirus B19 and blood transfusion - an update.A newly identified bocavirus species in human stool.Comparative analysis reveals frequent recombination in the parvoviruses.Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.Human immunodeficiency virus/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China.Clinical aspects of parvovirus B19 infection.Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infectionsExistence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008.Molecular characterization of human parvovirus B19 genotypes 2 and 3.Epidemiology of two human protoparvoviruses, bufavirus and tusavirus.Identification and characterization of persistent human erythrovirus infection in blood donor samples.Viral myocarditis: from experimental models to molecular diagnosis in patients.Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.Human Parvoviruses.Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests.Identification of recombination in the NS1 and VPs genes of parvovirus B19.Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.Genome characterization of a novel porcine bocavirus.The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.Variability of parvovirus B19 genotype 2 in plasma products with different compositions in the inactivation sensitivity by liquid-heating.Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells.Different susceptibility of B19 virus and mice minute virus to low pH treatment.Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
P2860
Q24811737-38B65805-52F1-472F-B2F4-66C2F88CF0C1Q27468863-D918E604-3076-4BCF-BEC1-3F7C43880FB8Q27472851-65CA2269-280E-4DDA-8A79-516D32E65FB1Q30571511-866D0810-1AB1-4042-BCBE-83501CBEF41DQ33303924-6EA879DF-A4AD-40AE-AE95-A23860D80699Q33614182-E697E09F-83B3-473B-B978-0106E38DEDB2Q34043407-9D67F3C1-776E-4088-8073-D1D340C4A14DQ34120900-D0033A32-FD7A-4C51-9918-BCA9E3E20008Q34120947-EF14640E-B9E4-4E5B-8ACB-C04677B6DD32Q34124006-21F34F2C-A9D1-4DBA-AB01-AC943E08D73DQ34430679-2C4A7F37-B58D-4436-B2F7-3840DE6AC587Q34569072-33446382-8F18-4E32-83A2-6D3C761775B8Q34624583-AE9A9016-FB9D-4B6E-9702-65A9022D8979Q34625443-801D4F81-0CC0-4CED-8058-5F3E9D5E06A1Q34660084-31B5340F-09C7-4D82-A94B-9805671EAC6BQ34900621-5D909E6E-AE5C-43C2-BF95-22E2847103ABQ35888909-1C18E1B7-FF19-4802-ADE4-700F75555869Q36326300-29B421F4-4B40-49DD-A66E-1D778A122DC5Q36393530-9D074F3C-4275-4A3F-808E-04328BB41FFBQ36589340-5AE4F2EA-131A-46B3-985D-30E9D5F7B0A5Q36747943-5BB395CC-2294-44FD-AB40-54E95DFEC89EQ37263290-73FFBFAE-02E2-41A6-BEEE-691AFFC20A5DQ37410780-E254F3AF-A61C-4631-90E0-A232609753B5Q37465311-9E358199-4297-4CA5-AAC2-F43467AF78AAQ37501495-1ED8FF72-BDC6-4B52-B63C-3ABC9215C752Q37596753-3ECD1113-C339-4CCF-977A-29E4A7D764D1Q38052447-45926D86-594C-43AF-BCD9-3D85980E197CQ38393265-E056E7BD-BE5E-458F-8C54-194298EF1452Q38996997-F333DA0E-890C-4BBB-A71E-417249536D35Q40834278-5DFEBFE8-8AC1-4BB3-AD4C-5665DC7E28C0Q40983850-EFEC7D58-D5A9-4ED5-9040-0C25F30DEC85Q41430956-621490EC-4222-4C09-98F1-3CA4CCFBEB8DQ41868019-6EB554B5-47DD-485D-A528-40765F430A12Q43555620-0DDE6969-00FA-4D5F-93BE-1DD544A4F6F0Q43901288-79D5E1A5-A3D4-46AD-AA30-466FD9EA0912Q44238813-CD707006-0684-4EBC-8AA6-E08A685C44EEQ44852251-8AB64D66-341F-4478-936D-E57BE4F1319AQ45061283-3F1F174A-CFEB-4A03-9D41-D6E0860A4FBFQ45620572-245825D4-0962-4611-B412-676E735128A1Q46428631-061CB237-BD10-467E-AEE3-707AC8D1DDBA
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
A new parvovirus genotype persistent in human skin.
@en
type
label
A new parvovirus genotype persistent in human skin.
@en
prefLabel
A new parvovirus genotype persistent in human skin.
@en
P2093
P356
P1433
P1476
A new parvovirus genotype persistent in human skin.
@en
P2093
Annamari Ranki
Esa K Partio
Kati Hokynar
Maria Pesonen
Olli Kiviluoto
P304
P356
10.1006/VIRO.2002.1673
P407
P577
2002-10-01T00:00:00Z